Domovský ústav: Biomedicínske centrum SAV, v. v. i.
Biomedical Research Center
Slovak Academy of Sciences
Dubravska cesta 9
845 05 Bratislava
Edited by the care of Institute of Experimental Endocrinology, Biomedical Research Center,
Slovak Academy of Sciences
ISSN 1336-0329 (online edition)
ISSN 1210-0668 (printed edition)
Abstracted in PubMed, Medline/Index Medicus, Embase/Excerpta Medica
Published quarterly in English language.
Distributed by Sciendo/de Gruyter
Sona SCSUKOVA, Boris MRAVEC
BUJNAKOVA MLYNARCIKOVA Alzbeta
AQUILERA Greta – USA
ARANDA Ana – Spain
BENDLOVA Bela – Czech Republic
BRTKO Julius – Slovakia
DVORAK Zdenek – Czech Republic
FILATEROVA Ludmila – Russia
GASPERIKOVA Daniela – Slovakia
GREGORASZCZUK Ewa Lucja – Poland
HALUZIK Martin – Czech Republic
HERICHOVA Iveta – Slovakia
HERMAN James P. – USA
JAKOVLJEVIC Vladimir L. – Serbia
JEZOVA Daniela – Slovakia
KOHRLE Josef – Germany
MACHO Ladislav – Slovakia
MINCHENKO Oleksandr H. – Ukraine
MIKKELSEN Jens D. – Denmark
NAGY Gyorgy Miklos – Hungary
NAGYOVA Eva – Czech Republic
PACAK Karel – USA
PALKOVITS Miklos – Hungary
PODOBA Jan – Slovakia
SAAVEDRA Juan – USA
STRBAK Vladimir – Slovakia
TKAC Ivan – Slovakia
ZELENA Dora – Hungary
Endocrine Regulations (since 1967 to 1990 Endocrinologia Experimentalis) is an international journal devoted to publish outstanding original articles and reviews in experimental and clinical endocrinology. Manuscripts dealing with molecular and cellular endocrinology, neuroendocrinology/signal transduction, metabolism and diabetes, pharmacology, and genetic aspects of endocrinology will be considered.
Endocrine Regulations has now moved to online submission and review system: Editorial Manager - Endocrine Regulations.
INSTRUCTIONS FOR AUTHORS
Research Articles: are considered for publication if they describe significant, new and carefully confirmed findings supported with adequate experimental details.
Authors should follow the following outline:
Title page: a) title, b) short running title (limit: 8 words), c) name of the author (no titles or academic grades) and address of the institute(s), d) complete mailing address of corresponding author including telephone and telefax numbers and e-mail addresses.
Page 2: a) an abstract containing not more than 250 words with no abbreviations, b) keywords (limit: 8 words).
Next pages: a) introduction also indicating the aim of the study, b) materials and methods, c) results (double presentation of data in the form of text, tables or ﬁgures should be avoided), d) discussion, e) acknowledgements f) list of references, g) legends of tables and ﬁgures.
References should be assembled in alphabetical order according to the first author. More papers from the same author(s) in the same year must be identified by the letters a, b, c etc. placed after the year of publication. All listed references must be cited in the text as follows:
• Journal Articles: Itoh M, Okugawa T, Shiratori N, Ohashi H: Treatment with triiodothyronine (T3) against multinodular goiter fails to prevent the onset of Graves disease. Endocrine Regul 29, 151-156, 1995.
• Book Chapters: Mornex R, Orgiazzi JJ: Hyperthyroidism. In: The Thyroid Gland (Ed. M de Visscher), pp. 279-362, Raven Press, New York 1980.
• Books: Podoba J: Endemic goiter in Slovakia. VEDA, Bratislava, 1962.
When your electronic artwork is finalised, save it as or convert the images into JPG or TIFF formats. For color or grayscale photographs (halftones): always use a minimum of 300 dpi.
Each illustration should have a caption. Captions should be supplied separately. Keep the text of the illustrations in a minimum description and explain all symbols and abbreviations used.
The tables should be numbered consecutively in accordance with their appearance in the text. The data presented in tables should not be duplicated in the results or described elsewhere in the article.
Case Reports: are considered for publication if they describe new and carefully confirmed clinical findings. The manuscript preparation should follow the Instructions for Research articles outline with the following alterations: Methods, Results and Discussion can be written as a one section.
Short Communications: are manuscripts containing new clinical and experimental data of smaller scope. They should not exceed 3 printed pages and may include 1 table and 1 ﬁgure. The list of references at the end of the paper should not exceed 10 citations. The manuscript preparation should follow the Instructions for Research articles outline with the following alterations: a) no keywords and b) Methods, Results and Discussion can be written as a one section.
Review Articles: should cover a specific topic of endocrinology. They do not only to be exhaustive reviews, but also shorter articles intended either to draw attention to developments in a specific field or to bring observations over a wide area which seems to point in a new direction.
Special Issues: The journal welcomes proposals for special issues on topics that fall within the scope of the journal. The proposal should identify prospective papers and authors and give an indication of the time-scale in which the special issue could be produced.
Submission to Endocrine Regulations uses electronic manuscript submission. Follow the link to Editorial Manager - Endocrine Regulations. If this is your first submission to Endocrine Regulations, click on "Register Now" to create an author account. If you already have an account, enter your username and password to submit a new or revised manuscript. If you forget your password, do not create a new author account. Please, contact the Editor in Chief by E-mail for assistance.
The manuscript should be written in a correct English language (American or British usage is accepted, but not a mixture of these).
Instructions for Reviewers
We greatly appreciate the time and effort given by reviewers in evaluating papers for publication in our journal. Research articles and communications are reviewed by a minimum of two reviewers, review papers by at least three. While preparing the reports, the Referees are asked to follow the reviewer questionary which is available in the Editorial Manager system for Endocrine Regulations. Reviewers are kindly requested to deliver their final reports in the assigned time.